| Literature DB >> 12546415 |
Shinichi Sakemi1, Hideo Hirai, Toshio Ichiba, Taisuke Inagaki, Yoshinao Kato, Nakao Kojima, Hiroyuki Nishida, Janice C Parker, Toshiyuki Saito, Hiroko Tonai-Kachi, Maria A VanVolkenburg, Nobuji Yoshikawa, Yasuhiro Kojima.
Abstract
High-throughput screening of microbial extracts using rat hepatic microsomal glucose-6-phosphatase (G6Pase) led us to find thielavin B as a G6Pase inhibitor with inhibition of glucose output from glucagon-stimulated hepatocytes. Further searching for more potent analogs identified 11 new thielavins F-P in addition to the known thielavins A and B from a fungus Chaetomium carinthiacum ATCC 46463. Thielavin G showed the strongest activity as a G6Pase inhibitor (IC50=0.33 microM), while the IC50 of thielavin B was 5.5 microM. According to the structure-activity relationship, including authentic thielavins C, D and 3 partial hydrolysates from thielavins A and B, 3 benzoic acid-units and carboxylic acid functions are essential for G6Pase inhibition.Entities:
Mesh:
Substances:
Year: 2002 PMID: 12546415 DOI: 10.7164/antibiotics.55.941
Source DB: PubMed Journal: J Antibiot (Tokyo) ISSN: 0021-8820 Impact factor: 2.649